Clinical Trial Update: Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing Bimzelx (bimekizumab) for adult-onset pityriasis rubra pilaris is listed under Mayo Clinic sponsorship. The study status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pityriasis Rubra Pilaris

Drugs mentioned

• BIMZELX (BIMEKIZUMAB)

Snippet

Sponsor: Mayo Clinic | Conditions: Pityriasis Rubra Pilaris | Phase 4 | Status: NOT_YET_RECRUITING